Cresanto Global Limited shareholders approved the relocation of the company's registered office from Uttar Pradesh to Maharashtra at its 34th Annual General Meeting. The meeting, held on August 31, 2026, also saw the adoption of the audited standalone and consolidated financial statements for FY26.

The meeting commenced at 12:00 pm and concluded at 12:13 pm via video conferencing. Mr. Nishant Bajaj, Non-Executive Director, chaired the proceedings. A total of 26 members attended the meeting.

Key Resolutions Passed

Shareholders approved five resolutions during the meeting. The key outcomes include:

Meeting Details

The Company Secretary, Mrs. Pooja Abhijit Mandave, briefed members on participation guidelines. Remote e-voting was conducted through the NSDL platform from August 28, 2026, at 9:00 am to August 30, 2026, at 5:00 pm. Ms. Nidhi Bajaj served as the scrutinizer for the voting process.

Mr. Anurag Khandelia, representing M/s. K T P S & Co., the statutory auditors, was present at the meeting. The voting results were disseminated to BSE Limited and made available on the company website within two working days.

Cresanto Global Limited (formerly Raymed Labs Limited) reported a significant reduction in its quarterly loss for Q1FY26, posting a net loss of ₹5.88 lakh compared to ₹23.54 lakh in the preceding quarter ended March 31, 2026. The company recorded nil revenue from operations during the period.

The Board of Directors approved the unaudited financial results on August 13, 2026. The results were reviewed by K T P S & Co., Chartered Accountants, in accordance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Financial Performance

The company’s total income remained at nil for the quarter, continuing the trend from Q4FY25 where only minimal other income was recorded. Total expenses declined substantially, driving the improvement in the bottom line.

Employee benefits expenses stood at ₹0.46 lakh, down from ₹3.40 lakh in the previous quarter. Other expenses were ₹5.42 lakh, compared to ₹4.44 lakh in Q4FY25. Finance costs, which were ₹15.86 lakh in the prior quarter, were nil in Q1FY26.

What the Numbers Show

The sharp contraction in the net loss is primarily attributable to the elimination of finance costs and a reduction in employee benefits, rather than any operational revenue generation. With revenue from operations remaining at nil, the company continues to operate without core business income, relying on cost containment to reduce quarterly losses.